Products
News
Resources
Contact
Language
简体中文
繁體中文
English
日本語
한국어
Tiếng Việt
Overview
Latest
Regional
Industry
Featured
Multimedia
Other Languages
Public Company News
All
APAC
Global
All
APAC
Global
All
APAC
Global
All
APAC
Global
{{toptitleLeft}}
{{toptitleRight}}
{{selectTitle}}
{{toptitleLeft}}
{{index}}
{{select_list_per.name}}
Time
{{showName}}
{{weixin_name}}
X
{{listname}}
Loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.headline}}
{{storydata.create_time}}
{{storydata.headline}}
{{storydata.create_time}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
loading
The End
Network Errors Please Retry
Kazia calls for greater awareness of the deadliest gynecological cancer in the US
2019-05-08 20:00
Kazia calls for greater awareness of the most lethal women's disease in Australia
2019-05-08 09:55
Two Clinical Studies with IBI301, a Biosimilar Candidate to Rituximab, Met Primary Endpoints
2019-05-08 08:00
Connect Biopharma Reports Positive Phase 1 Data and Announces Initiation of Phase 1b Study in Patients with Atopic Dermatitis for Novel IL-4Rα Antibody CBP-201
2019-05-06 17:00
Scientific Advisory Board Announced for DELopen to Guide the Open Access DNA Encoded Library Interchange
2019-05-06 13:38
Harbour BioMed and Chia Tai Tianqing Pharmaceutical Group Ltd. Announce Strategic Alliance to Discover, Develop and Commercialize Innovative Biologics
2019-05-06 10:49
Samsung BioLogics signs CDO(Contract Development Organization) contract with GI Innovation
2019-05-03 14:36
CStone and Numab announce exclusive regional licensing agreement for ND021, a multi-functional drug candidate and potential next-generation immunotherapy
2019-05-02 11:05
3-V Biosciences Commences Dosing in Phase 2 Clinical Study of the FASN Inhibitor TVB-2640 in Patients with NASH
2019-05-01 06:00
FDA approves trade name Lexette(TM) (halobetasol propionate) foam, 0.05%
2019-04-30 22:35
Nimble Therapeutics Spins Out from Roche to Commercialize Novel Drug Discovery Technology with Financing from Telegraph Hill Partners
2019-04-30 22:00
China Biologic Products to Report First Quarter 2019 Financial Results
2019-04-30 20:00
GC Pharma Reports Q1 2019 Results
2019-04-30 15:37
Raman Singh Named One of Medicine Maker's Global Business Captains for Fifth Straight Year
2019-04-30 14:14
EirGenix, Inc. Enters Into Global License Agreement for the Commercialization of its Biosimilar Drug EG12014
2019-04-30 08:20
Elekta Files Patent Infringement Lawsuit Against ZAP Surgical Systems Inc.
2019-04-26 22:44
Sihuan Pharm's Innovative Digestive System Drug Anaprazole Sodium Achieved Early Completion of Patient Recruitment for Phase II Clinical Trial in China
2019-04-25 21:07
Can a novel, temporary, and fully resorbable surgical implant improve the outcome of common hockey and soccer injuries?
2019-04-24 16:00
HEC TaiGen Initiates Phase III Trial of Combination of Furaprevir and Yimitasvir for the Treatment of Chronic Hepatitis C Patients in China
2019-04-23 15:58
Rapid Medical Raises $20 Million in New Funding to Support Clinical and Commercialization of First-in-class Stroke Treatment Products
2019-04-23 09:00
1
318
319
320
321
322
401